Home›Stock Screener›Nureca

Nureca Share Price Today | Stock Price & Nureca Share Screener

NURECA Medical Equipment
Live Share Price NSE
₹342.60
▲ 3.95 (1.17%)
2026-08-07 00:00:00
Live Share Price BSE
₹320.50
▼ -12.50 (-3.75%)
2026-10-23 00:00:00

As of August 7, 2026, the live Nureca share price (NSE: NURECA) is ₹342.60 on NSE and ₹320.50 on BSE, up 1.17% from the previous close, with shares trading between ₹332.55 and ₹348.00 in today's trading session, and a 52-week range of ₹206.75–₹343.95. Check NURECA 52-week chart for the annual price range and momentum. Use the Nureca stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Nureca opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹36 and net income of ₹-6, with EBITDA of ₹-5, an operating margin of -16.0% and a profit margin of -16.7%.

Nureca Market Cap ₹302.57 Cr.
NURECA P/E Ratio (TTM) 71.98
Nureca P/B Ratio 1.73
EPS (TTM) ₹2.11
Dividend Yield -
Debt to Equity 0.02
NURECA 52 Week High ₹343.95
Nureca 52 Week Low ₹206.75
Operating Margin -16.00%
Profit Margin -16.67%
NURECA Revenue (TTM) ₹36.00
EBITDA ₹-5.00
Net Income ₹-6.00
Total Assets ₹196.00
Total Equity ₹181.00

Nureca Share Price Chart

Track the current stock price of Nureca with an interactive chart. Analyse NURECA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Nureca stock quote in one place.

The quote of ₹342.60 sits between the 52-week low of ₹206.75 and the 52-week high of ₹343.95, and the latest session moved 1.17% from the previous close.

Nureca Company Profile - Fundamental Screener

Screen Nureca company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for NURECA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE0DSF01015.

Company Details

Classification

Sector Healthcare
Industry Medical Equipment
Sub-Sector Medical Equipment
Segment E

Identifiers and Leadership

ISIN INE0DSF01015

Nureca Balance Sheet Screener

Screen NURECA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹196, down from ₹210 in 2025.

Latest statistics put total assets at ₹196 and shareholder funds at ₹181, with a leverage ratio of 0.02.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 196 210 205 207 219 186 34 24
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 14 9 7 9 10 4 1 1

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 2 3 3 3 4 4 9 0
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 181 194 193 195 203 163 15 8
Share Capital 10 10 10 10 10 10 0 0
Reserves & Surplus 171 184 183 185 193 153 15 8

Nureca Income Statement Screener - Profit & Revenue Analysis

Screen Nureca income statement and profit fundamentals. Analyze NURECA quarterly results. Nureca reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹36 and net profit was ₹-6, equal to earnings per unit of ₹-6.45, at an operating margin of -16%.

In that period expenses were ₹41, interest cost ₹0 and tax ₹1. The next period listed, 2026-Jun, shows revenue of ₹42 and net profit of ₹3.

Item 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar

Revenue and Expenses

Revenue 36 42 34 37 40 42 16 26 34 28 23 24 35 28 43
Expenses 41 37 31 35 35 36 21 23 34 31 25 24 30 27 44

Operating Costs and Margins

EBITDA -5 5 3 2 6 5 -6 3 1 -3 -1 0 5 2 -1
Operating Profit % -16.00% 8.00% 4.00% -2.00% 9.00% 8.00% -26.00% -12.00% -8.00% -15.00% -16.00% -14.00% 4.00% -19.00% -7.00%
Depreciation 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax -6 4 2 1 5 5 -7 3 0 -3 -2 -1 4 1 -2
Tax 1 1 0 0 1 1 -2 1 0 -1 0 0 1 1 -1
Net Profit -6 3 3 1 4 4 -4 2 -1 -3 -2 -1 3 0 -1
EPS -6.45 3.21 2.47 0.81 3.63 3.91 -4.15 1.66 -0.48 -2.80 -1.53 -0.71 2.90 0.16 -1.40

Nureca Cash Flow Screener - Liquidity Fundamentals

Screen NURECA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹3, and net cash flow was an outflow of ₹2.

Over the same period, investing activities provided ₹15 and financing activities used ₹20.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities 3 -19 -3 10 1 35 -8 0
Investing Activities 15 8 18 -17 -3 -110 0 0

Financing and Net Cash

Financing Activities -20 0 -1 -2 -7 92 8 0
Net Cash Flow -2 -11 14 -8 -9 17 0 0

Nureca Shareholding Pattern Screener

See Nureca shareholding pattern with promoter, FII, and DII holdings. Check Nureca promoter holding and ownership changes for NURECA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 68.09%, foreign institutions 0.08%, domestic institutions 0.04% and the public 29.73%, spread across 35,800 shareholders.

The shareholder count was 35,800 in 2026-Jan, compared with 34,558 in 2026-Mar.

Item 2026-Jan 2026-Mar 2026-Jun 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 68.09% 68.09% 68.09% 64.30% 64.33% 64.97% 64.97% 63.24%

Institutional Investors

FII Holding 0.08% 0.28% 0.11% 1.07% 0.08% 0.08% 0.08% 0.08%
DII Holding 0.04% 0.24% 0.24% 0.04% 0.04% 0.04% 0.04% 0.02%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 29.73% 28.83% 29.06% 32.39% 33.12% 32.15% 32.95% 33.73%
Other Holding 2.06% 2.56% 2.51% 2.20% 2.45% 2.77% 1.97% 2.94%
Shareholder Count 35,800 34,558 33,979 39,304 38,075 37,468 35,801 45,996

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Nureca. Nureca dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.00 0.00%
2023-March ₹0.00 0.00%
2022-March ₹3.00 1.00%
2021-March ₹2.00 0.15%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Nureca Stock Index Membership - Nifty & Sensex

See which indices include Nureca stock. Check NURECA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Nureca is not part of any tracked indices.
Only major market indices are tracked in our system.

Nureca Market Events Screener - Corporate Actions

Get Nureca corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Nureca stock events that may affect NURECA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated October 21, 2026, with a record date of October 21, 2026.

It is followed by Annual General Meeting dated July 28, 2026 and Quarterly Result Announcement dated July 21, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-10-21 2026-10-21 Quarterly Result Announcement NA -2.56%
2026-07-28 2026-07-28 Annual General Meeting NA 14.13%
2026-07-21 2026-07-21 Quarterly Result Announcement NA 14.63%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 1.55%
2026-01-17 2026-01-17 Quarterly Result Announcement NA 9.95%
2025-12-12 2025-12-18 Buyback 330 -1.09%
2025-10-16 2025-10-16 Quarterly Result Announcement NA 2.50%
2025-07-15 2025-07-15 Quarterly Result Announcement NA 1.19%
2025-06-16 2025-06-16 Annual General Meeting NA 21.94%
2025-05-05 2025-05-05 Quarterly Result Announcement NA -7.74%
2025-01-24 2025-01-24 Quarterly Result Announcement NA -7.31%
2024-10-24 2024-10-24 Quarterly Result Announcement NA -0.10%
2024-07-18 2024-07-18 Annual General Meeting NA -0.86%
2022-02-24 2022-02-25 Dividend ₹ 3.00 /share -18.28%
2021-09-21 2021-09-23 Dividend ₹ 2.00 /share 5.49%

Nureca Competitors Screener - Peer Stocks Comparison

Screen NURECA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Poly Medicure 15,718 51.67 1,995 13.43% 321 34.41
Tarsons Products 1,677 158.28 447 9.38% 14 43.65
Q-Line Biotech 1,395 26.32 347 7.89% 56 41.75
Laxmi Dental 1,000 32.82 286 18.15% 26 33.55
Hemant Surgical Industries 898 47.15 238 112.99% 18 60.38
Vasa Denticity 770 71.34 283 12.77% 10 49.82
Osel Devices 616 21.44 295 57.88% 29 38.56
Fabtech Technologies 589 11.94 431 28.40% 38 35.96
Prevest Denpro 486 22.55 77 14.31% 21 59.41
QMS Medical Allied Services 342 26.28 174 10.27% 12 49.00

Nureca Company Announcements - News & Reports Screener

Screen NURECA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 21, 2026.

The next most recent announcements are dated October 19, 2026 and October 18, 2026.

Date Update Actions
2026-10-21 Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements )Regulations2015 -
2026-10-19 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-18 Board Meeting Intimation for Considering And Approving Inter-Alia The Un-Audited Financial Results (Standalone And Consolidated) Of The Company For Quarter And Half Year Ended September 30 2026. -
2026-10-01 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-30 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-29 Closure of Trading Window -
2026-09-29 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-28 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-26 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-25 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-10 "Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-09-10 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-10 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 -
2026-09-09 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 ( PIT Regulations ) -
2026-08-29 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations) -
2026-08-11 Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 ( PIT Regulations ). -
2026-08-10 Additional Details Required For Corporate Announcement Under Regulation 30(4) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-08-07 Pendency Of Litigation(S)/Dispute(S) Or The Outcome Impacting The Company. -
2026-07-28 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-07-28 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹342.60, within a 52-week range of ₹206.75 to ₹343.95. The P/E ratio is 71.98 and the P/B ratio is 1.73, with earnings per unit of ₹2.11. Market capitalisation stands at ₹302.57 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 24, 2026. This page covers 8 balance sheet periods, 15 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.